Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy.
Robotto A, Lembo D, Quaglino P, Brizio E, Polato D, Civra A, Cusato J, Di Perri G. Robotto A, et al. Among authors: quaglino p. Environ Res. 2022 Jan;203:111901. doi: 10.1016/j.envres.2021.111901. Epub 2021 Aug 19. Environ Res. 2022. PMID: 34419466 Free PMC article.
Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study.
Mitsunaga K, Bagot M, Ram-Wolff C, Guenova E, von Gugelberg C, Hodak E, Amitay-Laish I, Papadavid E, Jonak C, Porkert S, Scarisbrick J, Applewaite R, Beylot-Barry M, Nicolay J, Quaglino P, Sanches JA, Cury-Martins J, Lora-Pablos D, Ortiz P. Mitsunaga K, et al. Among authors: quaglino p. Br J Dermatol. 2024 Apr 10:ljae152. doi: 10.1093/bjd/ljae152. Online ahead of print. Br J Dermatol. 2024. PMID: 38596857
Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
Blanchard M, Morren MA, Busschots AM, Hauben E, Alberti-Violetti S, Berti E, Avallone G, Tavoletti G, Panzone M, Quaglino P, Colonna C, Melchers RC, Vermeer MH, Gniadecki R, Mitteldorf C, Gosmann J, Stadler R, Jonak C, Oren-Shabtai M, Hodak E, Friedland R, Gordon E, Geskin LJ, Scarisbrick JJ, Mayo Martínez F, Noguera Morel L, Pehr K, Amarov B, Faouzi M, Nicolay JP, Kempf W, Blanchard G, Guenova E. Blanchard M, et al. Among authors: quaglino p. Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093/bjd/ljae150. Online ahead of print. Br J Dermatol. 2024. PMID: 38595050
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
Roccuzzo G, Calvão J, Dobos G, Morsia E, Mozas P, Peterknecht E, Schrader AMR, Zottarelli F, Bagot M, Stadler R, Vermeer M, Quaglino P, Scarisbrick J. Roccuzzo G, et al. Among authors: quaglino p. Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093/bjd/ljae145. Online ahead of print. Br J Dermatol. 2024. PMID: 38576352 No abstract available.
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Bai X, Shaheen A, Grieco C, d'Arienzo PD, Mina F, Czapla JA, Lawless AR, Bongiovanni E, Santaniello U, Zappi H, Dulak D, Williamson A, Lee R, Gupta A, Li C, Si L, Ubaldi M, Yamazaki N, Ogata D, Johnson R, Park BC, Jung S, Madonna G, Hochherz J, Umeda Y, Nakamura Y, Gebhardt C, Festino L, Capone M, Ascierto PA, Johnson DB, Lo SN, Long GV, Menzies AM, Namikawa K, Mandala M, Guo J, Lorigan P, Najjar YG, Haydon A, Quaglino P, Boland GM, Sullivan RJ, Furness AJS, Plummer R, Flaherty KT. Bai X, et al. Among authors: quaglino p. EClinicalMedicine. 2024 Mar 27;71:102564. doi: 10.1016/j.eclinm.2024.102564. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38572079 Free PMC article. No abstract available.
Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk.
Boskovic S, Borriello S, D'Ascenzo F, Sciamarrelli N, Rosset F, Mastorino L, Paolo D, Bocchino PP, De Filippo O, Ribero S, De Ferrari G, Quaglino P. Boskovic S, et al. Among authors: quaglino p. Expert Opin Biol Ther. 2024 Apr 1:1-3. doi: 10.1080/14712598.2024.2337242. Online ahead of print. Expert Opin Biol Ther. 2024. PMID: 38557408 No abstract available.
Corrigendum to "Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial" [Eur J Cancer 199 (2024) 113531].
Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, Guida M, Quaglino P, Guidoboni M, Marchetti P, Simonetti E, Santangelo F, Amato G, Covre A, Camerini R, Valente M, Mandalà M, Giannarelli D, Calabrò L, Maio M. Di Giacomo AM, et al. Among authors: quaglino p. Eur J Cancer. 2024 May;202:113981. doi: 10.1016/j.ejca.2024.113981. Epub 2024 Mar 9. Eur J Cancer. 2024. PMID: 38461074 No abstract available.
537 results